Blockman, BCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2025-01-092025-01-092020-12-15Blockman M, Cohen K, De Waal R, Kredo T, et al. Remdesivir for COVID-19: evidence review of the clinical benefits and harms. South African National Department of Health; 15 December 2020.http://www.health.gov.za/wp-content/uploads/2020/12/Rapid-Review-of-Remdesivir-for-COVID-19-Update_15December2020.pdfhttps://hdl.handle.net/11288/598083enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Remdesivir for COVID-19RemdesivirEvidence review of clinical benefit and harm of remdesivirPatients with confirmed COVID-19SARS-CoV-2 Antiviral AgentRemdesivir for COVID-19: Evidence review of the clinical benefits and harmsTechnical Report